A randomized phase II trial of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin in previously untreated patients with advanced gastric cancer
Latest Information Update: 27 Feb 2017
Price :
$35 *
At a glance
- Drugs Oxaliplatin (Primary) ; Cisplatin; Docetaxel
- Indications Gastric cancer
- Focus Therapeutic Use
- 20 Sep 2009 Results for 75 patients were presented at the 15th European Cancer Conference and the 34th Congress of the European Society for Medical Oncology (ECCO/ESMO 2009)
- 02 Jun 2009 Results for 61 patients were presented at the 45th Annual Meeting of the American Society of Clinical Oncology.
- 15 Jan 2009 Results for 51 patients were presented at the 2009 Gastrointestinal Cancers Symposium.